Show simple item record

dc.contributor.authorAlazzam, Mo'iad
dc.contributor.authorTidy, John
dc.contributor.authorOsborne, Raymond
dc.contributor.authorColeman, Robert
dc.contributor.authorHancock, Barry W
dc.contributor.authorLawrie, Theresa A
dc.date.accessioned2013-02-25T14:24:01Z
dc.date.available2013-02-25T14:24:01Z
dc.date.issued2012-12
dc.identifier.citationChemotherapy for resistant or recurrent gestational trophoblastic neoplasia. 2012, 12:CD008891 Cochrane Database Syst Reven_GB
dc.identifier.issn1469-493X
dc.identifier.pmid23235667
dc.identifier.doi10.1002/14651858.CD008891.pub2
dc.identifier.urihttp://hdl.handle.net/10147/270372
dc.description.abstractGestational trophoblastic neoplasia (GTN) is a highly curable group of pregnancy-related tumours; however, approximately 25% of GTN tumours will be resistant to, or will relapse after, initial chemotherapy. These resistant and relapsed lesions will require salvage chemotherapy with or without surgery. Various salvage regimens are used worldwide. It is unclear which regimens are the most effective and the least toxic.
dc.language.isoenen
dc.relation.urlhttp://onlinelibrary.wiley.com/doi/10.1002/14651858.CD008891.pub2/pdfen_GB
dc.rightsArchived with thanks to Cochrane database of systematic reviews (Online)en_GB
dc.subject.meshDrug Resistance, Neoplasm
dc.subject.meshFemale
dc.subject.meshGestational Trophoblastic Disease
dc.subject.meshHumans
dc.subject.meshNeoplasm Recurrence, Local
dc.subject.meshPregnancy
dc.titleChemotherapy for resistant or recurrent gestational trophoblastic neoplasia.en_GB
dc.typeSystematic Reviewen
dc.contributor.departmentDepartment of Gynaecology, The Galway Clinic, Doughiska, Galway, Ireland. moiad@doctors.org.uken_GB
dc.identifier.journalCochrane database of systematic reviews (Online)en_GB
dc.description.provinceConnachten
html.description.abstractGestational trophoblastic neoplasia (GTN) is a highly curable group of pregnancy-related tumours; however, approximately 25% of GTN tumours will be resistant to, or will relapse after, initial chemotherapy. These resistant and relapsed lesions will require salvage chemotherapy with or without surgery. Various salvage regimens are used worldwide. It is unclear which regimens are the most effective and the least toxic.


This item appears in the following Collection(s)

Show simple item record